Skip to main content

Table 4 Characteristics of included studies

From: Clinicians’ attitudes and perceived barriers and facilitators to cancer treatment clinical practice guideline adherence: a systematic review of qualitative and quantitative literature

First author

Sample size

Response rate %

Qual/Quanta

Method

MO

RO

Surg

Urologist

Others

Cancer streamb

Stage

Country

CPG focusc

O'Brien (2016) [54]

28

68%

Qual

Interview

Y

Y

Y

-

Breast

Positive SLNB

Canada

cALND after positive sentinel lymph node biopsy (SLNB) regional CPG

Shelton (2019) [55]

42

Qual

Interview

Y

Y

-

Y

Colon

Stage II

USA

Adjuvant chemotherapy for colon cancer national CPGs (ASCO or the NCCN)

Otte (2017) [53]

14

Qual + Quant

Interview including Q card sorting

Y

-

Pancreatic ductal adeno-carcinoma

Locally advanced, UICC Stage III cT4N1M0

Germany

Exocrine pancreatic adenocarcinoma Treatment CPGs, including recommendations for active cancer treatment and treatment with palliative intent

Brouwers (2014) [56]

71

30%

Qual + Quant

Surveys + interviews

Y

Y

Y

-

NSCLC

Stage II/IIIA resected NSCLC and unresected stage IIA/B NSCLC

Canada

1. CCOPGI Chemotherapy CPG: stage II/IIIA resected NSCLC patients 2. CCOPGI Chemotherapy + radiation: unresected stage IIIA/B NSCLC patients

Bristow (2018) [57]

128

-

Quant

Survey

Y

Y

Y

Prostate

Post-Prostatectomy

Canada

ASTRO and AUA Adjuvant and salvage post prostatectomy radiotherapy CPGs

Brown (2016) [58]

157

45%

Quant

Survey

Y

Y

Prostate

Locally advanced

Australia

ACN Adjuvant radiotherapy treatment for prostate cancer CPG

Carrick (1998) [59]

150

64%

Quant

Survey

Y

-

Breast

Early stage

Australia

NHMRC Early breast cancer management CPG

Fonteyne (2018) [60]

126

18%

Quant

Survey

Y

Y

Y

Y

MIBC

Primary to metastatic

Belgium

Primary, Adjuvant and metastatic radiotherapy treatment for MIBC

Gattellari (2001) [61]

195

89%

Quant

Survey

Y

-

CRC

Australia

ANC/COSA CRC management CPGs

Graham (2007) [15]

520

57%

Quant

Survey

Y

Y

-

Y

Cancer

Canada

CCOPGI cancer management CPGs

Grilli (1991) [62]

770

41%

Quant

Survey

Y

Y

-

Y

Breast, CRC, Ovarian

Italy

Italian National CPGs for Breast, CRC, and ovarian cancer treatment

Ismaila (2018) [63]

101

53%

Quant

Survey

Y

-

Cancer

Nigeria

International, national, local oncology CPGs

Jagsi (2014) [64]

896

60%

Quant

Survey

Y

Y

-

Breast

USA

NCCN CPG for Breast cancer

Ward (1997) [65]

69

77%

Quant

Survey

Y

Y

Y

-

Y

Breast

Early stage

Australia

NHMRC early breast cancer CPG

White (2010) [66]

63 (survey)

58%

Quant

Survey + Patterns of care study

Y

-

Breast (DCIS)

DCIS

Australia

Australian treatment recommendations for DCIS

  1. aQual qualitative research, Quant quantitative research, MO medical oncologist, RO radiation oncologist, Surg surgeon
  2. bcALND completion axillary lymph node dissection, CRC colorectal cancer, DCIS ductal carcinoma in situ, MIBC muscle invasive bladder cancer, NSCLC non-small cell lung cancer
  3. cACN Australian Cancer Network; AUA American Urological Association; ASCO American Society of Clinical Oncology; ASTRO The American Society for Radiation Oncology, CCOPGI Cancer Care Ontario, Practice Guideline Initiative; COSA Clinical Oncology Society of Australia; NCCN National Comprehensive Cancer Network; NHMRC National Health and Medical Research Council; SLNB sentinel lymph node biopsy